HK1016973A1 - Benzazepine derivatives with vasopressin agonistic activity - Google Patents
Benzazepine derivatives with vasopressin agonistic activityInfo
- Publication number
- HK1016973A1 HK1016973A1 HK99101930A HK99101930A HK1016973A1 HK 1016973 A1 HK1016973 A1 HK 1016973A1 HK 99101930 A HK99101930 A HK 99101930A HK 99101930 A HK99101930 A HK 99101930A HK 1016973 A1 HK1016973 A1 HK 1016973A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- agonistic activity
- benzazepine derivatives
- vasopressin
- vasopressin agonistic
- benzazepine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP32613695 | 1995-12-15 | ||
| JP18950096 | 1996-07-18 | ||
| PCT/JP1996/003652 WO1997022591A1 (en) | 1995-12-15 | 1996-12-13 | Benzazepine derivatives with vasopressin agonistic activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1016973A1 true HK1016973A1 (en) | 1999-11-12 |
Family
ID=26505504
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK99101930A HK1016973A1 (en) | 1995-12-15 | 1999-04-28 | Benzazepine derivatives with vasopressin agonistic activity |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US6096736A (xx) |
| EP (1) | EP0877736B1 (xx) |
| KR (1) | KR100493503B1 (xx) |
| CN (1) | CN1104419C (xx) |
| AR (1) | AR005044A1 (xx) |
| AT (1) | ATE264845T1 (xx) |
| BR (1) | BR9612126A (xx) |
| DE (1) | DE69632268T2 (xx) |
| DK (1) | DK0877736T3 (xx) |
| ES (1) | ES2219703T3 (xx) |
| HK (1) | HK1016973A1 (xx) |
| MX (1) | MX9804849A (xx) |
| PT (1) | PT877736E (xx) |
| TW (1) | TW359669B (xx) |
| WO (1) | WO1997022591A1 (xx) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE277050T1 (de) * | 1997-07-30 | 2004-10-15 | Wyeth Corp | Trizyclische vasopressin agoniste |
| US6511974B1 (en) | 1997-07-30 | 2003-01-28 | Wyeth | Tricyclic vasopressin agonists |
| US6194407B1 (en) | 1997-07-30 | 2001-02-27 | American Home Products Corporation | Tricyclic pyrido vasopressin agonists |
| DK1000059T3 (da) * | 1997-07-30 | 2005-01-10 | Wyeth Corp | Tricycliske vasopressin-agonister |
| US7138393B2 (en) | 1998-07-24 | 2006-11-21 | Wyeth | Biologically active vasopressin agonist metabolites |
| US6090803A (en) * | 1998-07-24 | 2000-07-18 | American Home Products Corporation | Tricyclic vasopressin agonists |
| JP2004530668A (ja) | 2001-04-12 | 2004-10-07 | ワイス | バソプレッシンアゴニストとしてのｎ−ビフェニルカルボニル−およびｎ−フェニルピリジルカルボニル置換二および三環アゼピンおよびジアゼピン |
| CN1294134C (zh) | 2001-04-12 | 2007-01-10 | 惠氏公司 | 环己基苯基血管升压素激动剂 |
| CA2464069A1 (en) | 2001-11-16 | 2003-05-22 | Hiroyuki Koshio | 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzazepine derivative or salt thereof |
| DK1619185T3 (da) | 2003-04-28 | 2011-07-18 | Astellas Pharma Inc | 4,4-difluor-1,2,3,4-tetrahydro-5H-1-benzazepinderivat eller salt deraf |
| US8138342B2 (en) * | 2004-10-12 | 2012-03-20 | High Point Pharmacueticals, LLC | 11β-hydroxysteroid dehydrogenase type 1 active spiro compounds |
| GT200500317A (es) * | 2004-11-05 | 2006-10-27 | Proceso para preparar compuestos de quinolina y productos obtenidos de los mismos | |
| CA2604759A1 (en) * | 2005-04-22 | 2006-11-02 | Wyeth | Dihydrobenzofuran derivatives and uses thereof |
| GT200600164A (es) * | 2005-04-22 | 2007-03-14 | Derivados de dihidrobenzofuranos y usos de los mismos | |
| GT200600158A (es) * | 2005-04-22 | 2006-11-28 | Cristales formados de clorhidrato de {[(2r)-7-(2,6-diclorofenil)-5-fluoro-2,3-dihidro-1-benzofurano-2-il]metil}amina | |
| CN101203218A (zh) * | 2005-04-22 | 2008-06-18 | 惠氏公司 | 苯并呋喃基链烷胺衍生物和其作为5－ht2c激动剂的用途 |
| GT200600162A (es) * | 2005-04-24 | 2007-03-14 | Metodos para modular la funcion de la vejiga | |
| AR054849A1 (es) * | 2005-07-26 | 2007-07-18 | Wyeth Corp | Diazepinoquinolinas, sintesis de las mismas, e intermediarios para obtenerlas |
| EP1948190A2 (en) * | 2005-11-01 | 2008-07-30 | Transtech Pharma | Pharmaceutical use of substituted amides |
| JP2009513611A (ja) * | 2005-11-01 | 2009-04-02 | ハイ ポイント ファーマシューティカルズ，リミティド ライアビリティ カンパニー | 置換アミドの医薬用途 |
| TW200734334A (en) * | 2006-01-13 | 2007-09-16 | Wyeth Corp | Treatment of substance abuse |
| WO2007107550A1 (en) * | 2006-03-21 | 2007-09-27 | High Point Pharmaceuticals, Llc | Adamantane derivatives for the treatment of the metabolic syndrome |
| CN101410118A (zh) * | 2006-03-24 | 2009-04-15 | 惠氏公司 | 疼痛的治疗 |
| PA8720801A1 (es) * | 2006-03-24 | 2008-11-19 | Wyeth Corp | Nuevas combinaciones terapeuticas para el tratamiento de la depresion |
| CA2648074A1 (en) | 2006-04-07 | 2007-10-18 | High Point Pharmaceuticals, Llc | 11.beta.-hydroxysteroid dehydrogenase type 1 active compounds |
| US20090306048A1 (en) * | 2006-06-16 | 2009-12-10 | John Paul Kilburn | Pharmaceutical use of substituted piperidine carboxamides |
| EP2044073A1 (en) * | 2006-07-13 | 2009-04-08 | High Point Pharmaceuticals, LLC | 11beta-hydroxysteroid dehydrogenase type 1 active compounds |
| EP1878721A1 (en) * | 2006-07-13 | 2008-01-16 | Novo Nordisk A/S | 4-Piperidylbenzamides as 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors |
| WO2008101885A1 (en) * | 2007-02-23 | 2008-08-28 | High Point Pharmaceuticals, Llc | N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase |
| WO2008101886A1 (en) * | 2007-02-23 | 2008-08-28 | High Point Pharmaceuticals, Llc | N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase |
| JP2010519242A (ja) * | 2007-02-23 | 2010-06-03 | ハイ ポイント ファーマシューティカルズ，リミティド ライアビリティ カンパニー | 新規化合物 |
| EA016951B1 (ru) | 2007-02-23 | 2012-08-30 | ХАЙ ПОЙНТ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи | N-АДАМАНТИЛБЕНЗАМИДЫ В КАЧЕСТВЕ ИНГИБИТОРОВ 11-β-ГИДРОКСИСТЕРОИДДЕГИДРОГЕНАЗЫ |
| CN101652359A (zh) * | 2007-03-09 | 2010-02-17 | 高点制药有限责任公司 | 作为羟类固醇脱氢酶抑制剂的吲哚-和苯并咪唑酰胺类 |
| CA2681934A1 (en) * | 2007-03-28 | 2008-10-02 | High Point Pharmaceuticals, Llc | 11beta-hsd1 active compounds |
| ES2399912T3 (es) * | 2007-04-11 | 2013-04-04 | High Point Pharmaceuticals, Llc | Nuevos compuestos |
| JP2010526777A (ja) * | 2007-04-24 | 2010-08-05 | ハイ ポイント ファーマシューティカルズ，リミティド ライアビリティ カンパニー | 置換アミドの医薬用途 |
| CL2008002777A1 (es) * | 2007-09-21 | 2010-01-22 | Wyeth Corp | Metodo de preparacion de compuestos diazepinoquinolinicos quirales por recristalizacion en un sistema de solvente ternario. |
| GB201005623D0 (en) | 2010-04-01 | 2010-05-19 | Vantia Ltd | New polymorph |
| CA2889239C (en) | 2012-12-26 | 2020-10-27 | Katsunori Kitamoto | Benzoazepine derivative and medical use thereof |
| TWI643847B (zh) * | 2014-06-11 | 2018-12-11 | 日商三和化學研究所股份有限公司 | Novel benzoazepine derivatives and their medical uses |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0450097T3 (da) * | 1989-10-20 | 1996-05-20 | Otsuka Pharma Co Ltd | Benzoheterocykliske forbindelser |
| US5258510A (en) * | 1989-10-20 | 1993-11-02 | Otsuka Pharma Co Ltd | Benzoheterocyclic compounds |
| CA2066104C (en) * | 1991-04-19 | 2003-05-27 | Hidenori Ogawa | Benzazepine derivatives as vasopressin antagonists |
| JPH05320135A (ja) * | 1992-05-19 | 1993-12-03 | Yamanouchi Pharmaceut Co Ltd | テトラヒドロベンズアゼピン誘導体 |
| AU657424B2 (en) * | 1992-07-02 | 1995-03-09 | Otsuka Pharmaceutical Co., Ltd. | Oxytocin antagonist |
| TW270927B (xx) * | 1992-10-16 | 1996-02-21 | Otsuka Pharma Co Ltd | |
| AU6219994A (en) * | 1993-03-11 | 1994-09-26 | Yamanouchi Pharmaceutical Co., Ltd. | Compound with vasopressin antagonism |
| GB9307527D0 (en) * | 1993-04-13 | 1993-06-02 | Fujisawa Pharmaceutical Co | New venzamide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same |
| FR2714378B1 (fr) * | 1993-12-24 | 1996-03-15 | Sanofi Sa | Dérivés de l'indol-2-one substitués en 3 par un groupe azoté, leur préparation, les compositions pharmaceutiques en contenant. |
| DK1221440T3 (da) * | 1994-06-15 | 2007-09-17 | Otsuka Pharma Co Ltd | Benzoheterocykliske derivater der er nyttige som vasopressin- eller oxytocinmodulatorer |
-
1996
- 1996-11-25 TW TW085114489A patent/TW359669B/zh not_active IP Right Cessation
- 1996-12-12 AR ARP960105628A patent/AR005044A1/es active IP Right Grant
- 1996-12-13 CN CN96199950A patent/CN1104419C/zh not_active Expired - Fee Related
- 1996-12-13 BR BR9612126A patent/BR9612126A/pt not_active IP Right Cessation
- 1996-12-13 PT PT96941870T patent/PT877736E/pt unknown
- 1996-12-13 AT AT96941870T patent/ATE264845T1/de active
- 1996-12-13 DE DE69632268T patent/DE69632268T2/de not_active Expired - Lifetime
- 1996-12-13 ES ES96941870T patent/ES2219703T3/es not_active Expired - Lifetime
- 1996-12-13 WO PCT/JP1996/003652 patent/WO1997022591A1/en active IP Right Grant
- 1996-12-13 US US09/091,295 patent/US6096736A/en not_active Expired - Lifetime
- 1996-12-13 DK DK96941870T patent/DK0877736T3/da active
- 1996-12-13 EP EP96941870A patent/EP0877736B1/en not_active Expired - Lifetime
- 1996-12-13 KR KR10-1998-0704489A patent/KR100493503B1/ko not_active IP Right Cessation
-
1998
- 1998-06-15 MX MX9804849A patent/MX9804849A/es unknown
-
1999
- 1999-04-28 HK HK99101930A patent/HK1016973A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US6096736A (en) | 2000-08-01 |
| CN1104419C (zh) | 2003-04-02 |
| KR20000064406A (ko) | 2000-11-06 |
| KR100493503B1 (ko) | 2005-09-30 |
| ATE264845T1 (de) | 2004-05-15 |
| ES2219703T3 (es) | 2004-12-01 |
| CN1209121A (zh) | 1999-02-24 |
| DE69632268D1 (de) | 2004-05-27 |
| DK0877736T3 (da) | 2004-08-16 |
| EP0877736B1 (en) | 2004-04-21 |
| MX9804849A (es) | 1998-09-30 |
| WO1997022591A1 (en) | 1997-06-26 |
| EP0877736A1 (en) | 1998-11-18 |
| AR005044A1 (es) | 1999-04-07 |
| DE69632268T2 (de) | 2005-04-21 |
| BR9612126A (pt) | 1999-02-17 |
| PT877736E (pt) | 2004-09-30 |
| TW359669B (en) | 1999-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1016973A1 (en) | Benzazepine derivatives with vasopressin agonistic activity | |
| PL321938A1 (en) | Osteoprotegrin | |
| EP0858351A4 (en) | ANTI-SHUTTERING NEEDLE | |
| HK1003891A1 (en) | Tricyclic vasopressin antagonists | |
| GB2304027B (en) | Pretensioner | |
| GB9524038D0 (en) | Nozzle | |
| GB9520243D0 (en) | Injector | |
| GB9514863D0 (en) | Teleconferencing | |
| EP0847724A4 (en) | SPHYGMOMANOMETER | |
| GB9525369D0 (en) | Injector | |
| GB9521028D0 (en) | Monitors | |
| EP0777412A4 (en) | LATE-Fb PROMOTER | |
| EP0856314A4 (en) | IMMUNODEPRESSOR | |
| GB9514370D0 (en) | Backpack | |
| GB9508555D0 (en) | Spray reducing wheelarch | |
| GB9514864D0 (en) | Teleconferencing | |
| AU125274S (en) | Backpack | |
| GB9525365D0 (en) | Benzazepine derivatives | |
| GB9525388D0 (en) | Benzazepine derivatives | |
| GB9510922D0 (en) | Fastening arrangement | |
| CA76995S (en) | Backpack | |
| GB9525040D0 (en) | Design arrangement | |
| PL103336U1 (en) | Pillar | |
| PL103337U1 (en) | Pillar | |
| PL103430U1 (en) | Pillar |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PF | Patent in force | ||
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20151213 |